Literature DB >> 9440696

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes.

T J Hemesath1, E R Price, C Takemoto, T Badalian, D E Fisher.   

Abstract

Germline mutations at loci encoding the transcription factor Microphthalmia (Mi), the cytokine receptor c-Kit, or its ligand Steel factor (S1) result in strikingly similar defects in mast cell and melanocyte development. Here we describe a biochemical link between Kit signalling and the activity of Mi. Stimulation of melanoma cells with S1 results in activation of MAP kinase, which in turn phosphorylates Mi at a consensus target serine. This phosphorylation upregulates Mi transactivation of the tyrosinase pigmentation gene promoter. In addition to modulating pigment production, such signalling may regulate the expression of genes essential for melanocyte survival and development. The pathway represents a new application of the general MAP kinase machinery in transducing a signal between a tissue-specific receptor at the cell surface and a tissue-specific transcription factor in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440696     DOI: 10.1038/34681

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  157 in total

1.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

Authors:  M Wu; T J Hemesath; C M Takemoto; M A Horstmann; A G Wells; E R Price; D Z Fisher; D E Fisher
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

Review 2.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

3.  KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.

Authors:  Youl-Nam Lee; Stephanie Brandal; Pierre Noel; Erik Wentzel; Joshua T Mendell; Michael A McDevitt; Reuben Kapur; Melody Carter; Dean D Metcalfe; Clifford M Takemoto
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

4.  Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains.

Authors:  Roland P Kuiper; Marga Schepens; José Thijssen; Eric F P M Schoenmakers; Ad Geurts van Kessel
Journal:  Nucleic Acids Res       Date:  2004-04-26       Impact factor: 16.971

5.  Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway.

Authors:  Janet L Maldonado; Luika Timmerman; Jane Fridlyand; Boris C Bastian
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 6.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

7.  Involvement of MITF-A, an alternative isoform of mi transcription factor, on the expression of tryptase gene in human mast cells.

Authors:  Sun-Hee Lee; Jeong-Heon Lee; Jeong-Heon Lee; Dae-Ki Kim
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

8.  Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.

Authors:  Amir Sonnenblick; Carmit Levy; Ehud Razin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis.

Authors:  Akira Hachiya; Akemi Kobayashi; Yasuko Yoshida; Takashi Kitahara; Yoshinori Takema; Genji Imokawa
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 10.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.